Dysferlin interacts with affixin (beta-parvin) at the sarcolemma
- PMID: 15835269
- DOI: 10.1093/jnen/64.4.334
Dysferlin interacts with affixin (beta-parvin) at the sarcolemma
Abstract
The dysferlin gene is defective in Miyoshi myopathy (MM) and limb girdle muscular dystrophy type 2B (LGMD2B). Dysferlin is a sarcolemmal protein that is implicated in calcium-dependent membrane repair. Affixin (beta-parvin) is a novel, integrin-linked kinase-binding protein that is involved in the linkage between integrin and the cytoskeleton. Here we show that affixin is a dysferlin binding protein that colocalizes with dysferlin at the sarcolemma of normal human skeletal muscle. The immunoreactivity of affixin was reduced in sarcolemma of MM and LGMD2B muscles, although the total amount of the affixin protein was normal. Altered immunoreactivity of affixin was also observed in other muscle diseases including LGMD1C, where both affixin and dysferlin showed quite similar changes with a reduction of sarcolemmal staining with or without cytoplasmic accumulations. Colocalization of dysferlin and affixin was confirmed by immunofluorescence analysis using dysferlin-expressing C2 myoblasts. Wild-type and mutant dysferlin colocalized with endogenous affixin. The interaction of dysferlin and affixin was confirmed by immunoprecipitation study using normal human and mouse skeletal muscles. Using immunoprecipitation with deletion mutants of dysferlin, we have identified that C-terminal region of dysferlin is an apparent binding site for affixin. We also found N-terminal calponin homology domain of affixin as a binding site for dysferlin. Our results suggest that affixin may participate in membrane repair with dysferlin.
Similar articles
-
The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle.Hum Mol Genet. 2001 Aug 15;10(17):1761-6. doi: 10.1093/hmg/10.17.1761. Hum Mol Genet. 2001. PMID: 11532985
-
Defective membrane repair in dysferlin-deficient muscular dystrophy.Nature. 2003 May 8;423(6936):168-72. doi: 10.1038/nature01573. Nature. 2003. PMID: 12736685
-
Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb--girdle muscular dystrophies.Ann Neurol. 2000 Dec;48(6):902-12. Ann Neurol. 2000. PMID: 11117547
-
Dysferlin and the plasma membrane repair in muscular dystrophy.Trends Cell Biol. 2004 Apr;14(4):206-13. doi: 10.1016/j.tcb.2004.03.001. Trends Cell Biol. 2004. PMID: 15066638 Review.
-
Sarcolemmal proteins and the spectrum of limb-girdle muscular dystrophies.Semin Pediatr Neurol. 2002 Jun;9(2):81-99. doi: 10.1053/spen.2002.33795. Semin Pediatr Neurol. 2002. PMID: 12139001 Review.
Cited by
-
Lack of correlation between outcomes of membrane repair assay and correction of dystrophic changes in experimental therapeutic strategy in dysferlinopathy.PLoS One. 2012;7(5):e38036. doi: 10.1371/journal.pone.0038036. Epub 2012 May 29. PLoS One. 2012. PMID: 22666441 Free PMC article.
-
Dysfunction of dysferlin-deficient hearts.J Mol Med (Berl). 2007 Nov;85(11):1203-14. doi: 10.1007/s00109-007-0253-7. Epub 2007 Sep 9. J Mol Med (Berl). 2007. PMID: 17828519
-
Analysis of Dysferlin Direct Interactions with Putative Repair Proteins Links Apoptotic Signaling to Ca2+ Elevation via PDCD6 and FKBP8.Int J Mol Sci. 2023 Feb 28;24(5):4707. doi: 10.3390/ijms24054707. Int J Mol Sci. 2023. PMID: 36902136 Free PMC article.
-
Portrait of Dysferlinopathy: Diagnosis and Development of Therapy.J Clin Med. 2023 Sep 16;12(18):6011. doi: 10.3390/jcm12186011. J Clin Med. 2023. PMID: 37762951 Free PMC article. Review.
-
Differential Expression of Long Noncoding RNAs in Murine Myoblasts After Short Hairpin RNA-Mediated Dysferlin Silencing In Vitro: Microarray Profiling.JMIR Bioinform Biotechnol. 2022 Jun 17;3(1):e33186. doi: 10.2196/33186. JMIR Bioinform Biotechnol. 2022. PMID: 38935964 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous